Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount,...
Neurocrine Biosciences, Inc. (NBIX), a leading neuroscience-focused biopharmaceutical company, approaches the buy point amid growing market enthusiasm. The stock has surged more than...
On Thursday, Piper Sandler demonstrated confidence in The Trade Desk (NASDAQ:) shares by increasing the price target to $110 from the previous $105,...
In a recent transaction, Steven Keith Burke, the Senior Vice President and Chief Medical Officer of Akebia Therapeutics, Inc. (NASDAQ:), sold 27,000 shares...
(Reuters) -Blackstone looked set to clinch its $1.57 billion deal for Hipgnosis Songs Fund after Apollo-backed Concord said on Thursday it would stick...
Paramount Global’s vast entertainment empire would be broken up if a buyout bid from Sony Pictures Entertainment and Apollo Global Management succeeds, according...
